Barbro Linderholm - Publications, H-index & Citations

Barbro Linderholm

Institute of Clinical Sciences

34H指数

178论文数

6.2K被引数

收录论文 71

发表时间

De-Escalated Chemotherapy and Endocrine Therapy Outcomes in Young Women with Stage I HR+/HER2+ Breast Cancer: An International Real-World Study.在年轻女性中，针对I期HR+/HER2+乳腺癌的降级化疗和内分泌治疗效果：一项国际真实世界研究。

The Breast

IF0

2026-06-11

OAAI

Tal Sella; Frederieke van Duijnhoven; Hans Wildiers; Claudio Venieri; Katarzyna Pogoda; Barbro Linderholm; Leonor Matos; Natali Shirron; Eleonora De Maio D’Esposito; Nawale Hajjaji; Erika Matos; Lucía González Cortijo; Matteo Lambertini; Ana Fortuna; Laurent Rosset; Anastasia Constantinidou; Sofie Demasure; Areen Abu Remilah; Greet Huygh; Shani Paluch-Shimon

Author Correction: Advancing equitable access to innovation in breast cancer 作者更正：促进乳腺癌创新成果的公平获取

npj Breast Cancer

IF7.6

2025-12-16

OAAI

Seamus O’Reilly; Ines Vaz Luis; Virginie Adam; Evangelia D. Razis; Ander Urruticoechea; Amal Arahmani; Eva Carrasco; Boon H. Chua; Judith Bliss; Carolyn Straehle; Theodora Goulioti; Barbro Lindholm; Gustavo Werutsky; Etienne Brain; Philippe L. Bedard; Giuseppe Curigliano; Sherene Loi; Shigehira Saji; David Cameron

Adjuvant ovarian function suppression and aromatase inhibitors in premenopausal patients with hormone receptor and HER2 positive breast cancer, by timing of chemotherapy and trastuzumab and response to neoadjuvant therapy.辅助性卵巢功能抑制和芳香化酶抑制剂在激素受体和HER2阳性乳腺癌绝经前患者中的应用，按化疗和曲妥珠单抗的时机及新辅助治疗的反应。

The Breast

IF0

2025-12-06

OAAI

Ayelet Shai; Hans Wildiers; Claudio Venieri; Katarzyna Pogoda; Barbro Linderholm; Matteo Lambertini; Leonor Matos; Eleonora De Maio D’Esposito; Nawale Hajjaji; Erika Matos; Lucía González Cortijo; Giuseppe Fotia; Ana Fortuna; Tal Sella; Helena Gouveia; Laurent Rosset; Anastasia Constantinidou; Eurydice Angeli; Irfan Cicin; Vivianne Tjan-Heijnen

Correction: Changes in HER2low and HER2-ultralow status in 47 advanced breast carcinoma core biopsies, matching surgical specimens, and their distant metastases assessed by conventional light microscopy, digital pathology, and artificial intelligence 更正：在47例匹配手术标本及远处转移灶的晚期乳腺癌核心活检中，通过常规光学显微镜、数字病理学和人工智能评估HER2low和HER2-ultralow状态的变化。

Breast Cancer Research and Treatment

IF3

2025-09-26

OAAI

Anikó Kovács; Leif Klint; Barbro Linderholm; Toshima Z. Parris

Changes in HER2low and HER2-ultralow status in 47 advanced breast carcinoma core biopsies, matching surgical specimens, and their distant metastases assessed by conventional light microscopy, digital pathology, and artificial intelligence 使用常规光学显微镜、数字病理学和人工智能评估的47例匹配手术标本和远处转移灶的晚期乳腺癌核心活检中HER2low和HER2-ultralow状态的改变。

Breast Cancer Research and Treatment

IF3

2025-07-22

OAAI

Anikó Kovács; Leif Klint; Barbro Linderholm; Toshima Z. Parris

Advancing equitable access to innovation in breast cancer 促进乳腺癌创新的公平获取

npj Breast Cancer

IF7.6

2025-07-10

OAAI

Seamus O’Reilly; Ines Vaz Luis; Virginie Adam; Evangelia D. Razis; Ander Urruticoechea; Amal Arahmani; Eva Carrasco; Boon H. Chua; Judith Bliss; Carolyn Straehle; Theodora Goulioti; Barbro Lindholm; Gustavo Werustsky; Etienne Brain; Philippe L. Bedard; Giuseppe Curigliano; Sherene Loi; Shigehira Saji; David Cameron

Metronomic chemotherapy using capecitabine and cyclophosphamide in metastatic breast cancer - efficacy, tolerability and quality of life results from the phase II METRO trial (vol 78, 103795, 2004)口服卡培他滨和环磷酰胺的节拍化疗在转移性乳腺癌中的应用——来自II期METRO试验（第78卷，103795，2004年）的疗效、耐受性和生活质量结果

BREAST

IF7.9

2025-04-01

OAAI

Larsson, Karolina; Adra, Jamila; Klint, Leif; Linderholm, Barbro

Integration of personalised ultrasensitive ctDNA monitoring of patients with metastatic breast cancer to reduce imaging requirements

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2024-12-18

OAAI

Mouhanna, Pia; Stahlberg, Anders; Andersson, Daniel; Albu-Kareem, Ahmed; Elinder, Ellinor; Eriksson, Olle; Kavanagh, Amy; Kovacs, Aniko; Larsson, Karolina F.; Linderholm, Barbro; Uminska, Monika; Osterlund, Tobias; Howell, Sacha J.; Ekholm, Maria

Metronomic chemotherapy using capecitabine and cyclophosphamide in metastatic breast cancer - efficacy, tolerability and quality of life results from the phase II METRO trial

BREAST

IF7.9

2024-12-01

OAAI

Larsson, F. Karolina; Adra, Jamila; Klint, Leif; Linderholm, Barbro

A randomized trial of trastuzumab deruxtecan and biologydriven selection of neoadjuvant treatment for HER2-positive breast cancer (ARIADNE)一项曲妥珠单抗德鲁替康和生物驱动的 HER2 阳性乳腺癌新辅助治疗方案选择的随机试验（ARIADNE）

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Foukakis, T.; Naume, B.; Karakatsanis, A.; Andersson, A.; Barnekow, E.; Kessler, L. Edman; Einbeigi, Z.; Engebraten, O.; Killander, F.; Linderholm, B. K.; Schiza, A.; Valachis, A.; Bergh, J.; Villacampa, G.; Zouzos, A.; Hellstrom, M.; Hartman, J.; Matikas, A.

Safety and efficacy of trastuzumab deruxtecan and concomitant radiation therapy in patients with metastatic breast cancer: A multicentre international retrospective cohort study 曲妥珠单抗德鲁替康联合放疗在转移性乳腺癌患者中的安全性与有效性：一项多中心国际回顾性队列研究

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Visani, L.; Ratosa, I.; Linderholm, B. K.; Ribnikar, D.; Scialino, J.; Bertini, N.; Bonaparte, I.; Stefanovski, D.; Dobnikar, N.; Sojar, M.; Mattioli, C.; Valzano, M.; Salvestrini, V.; Becherini, C.; Morandi, A.; Livi, L.; Meattini, I.

Clinical and Genomic Features of ER-Positive/HER2-negative Metastatic Breast Cancer in AURORA Molecular Screening Initiative (BIG 14-01): Mechanisms of Endocrine Therapy Resistance and Implications for Adjuvant Approaches

CANCER RESEARCH

IF16.6

2024-05-02

PREAI

Guerrero-Zotano, Angel; Benelli, Matteo; Irrthum, Alexandre; Cameron, David; Ferrando, Lorenzo; Romagnoli, Dario; Paoli, Marta; Llinas, Arnau; Dadiani, Maya; Fimereli, Danai; Oliveira, Mafalda; Caballero, Carmela; Crestani, Thayane; Agostinetto, Elisa; Martins-Branco, Diogo; Hilbers, Florentine; Gal-Yam, Einav; Balic, Marija; Cardoso, Fatima; Reis-Filho, Jorge; Sotiriou, Christos; Curigliano, Giuseppe; Linderholm, Barbro; de Azambuja, Evandro; Knox, Susan; Rotaru, Cristina; Ciruelos, Eva; Davidson, Nancy E.; Viale, Giuseppe; Taylor, Donatienne; Canon, Jean-Luc; Calvo, Lourdes; Albanell, Joan; Colleoni, Marco; Duhem, Caroline; Harbeck, Nadia; Herremans, Catherine; Loibl, Sibylle; Marreaud, Sandrine; Scheepers, Elsemieke; Raimbault, Alice; Goulioti, Theodora; Vingiani, Andrea; Biagioni, Chiara; Vosberg, Sebastian; Zoppoli, Gabriele; Seoane, Jose; Venet, David; Aftimos, Philippe; Piccart, Martine

Current treatment landscape of HR+/HER2− advanced breast cancer in the Nordics: a modified Delphi study HR+/HER2−晚期乳腺癌在北欧地区的当前治疗格局：一项改良德尔菲研究

Acta Oncologica

IF2.2

2023-09-15

PREAI

Jürgen Geisler; Peeter Karihtala; Malgorzata Tuxen; Antonis Valachis; null; Barbro Holm; Cecilia Ahlin; Cathrine Bergquist Fosskaug; Jenny Bergqvist; Ana Bosch Campos; Eva Harder Brix; Erik Hugger Jakobsen; Anders Bonde Jensen; Oskar Johannsson; Minna Jääskeläinen; Torgunn Kursetgjerde; Barbro Linderholm; Henrik Lindman; Bård Mannsåker; Ulrik Narbe; Alina Carmen Porojnicu; Katri Selander; Silje Songe-Møller; Egil Støre Blix; Ann Søegaard Knop; Anna Thulin; Leena Tiainen; Anna Weder; Sophie Yammeni

Evaluation of the Sensitivity to Endocrine Therapy Index (SET2,3) in Early Male Breast Cancer: Results from an analysis in the EORTC 10085/TBCRC/BIG/NCTN International Male Breast Cancer Program

CANCER RESEARCH

IF16.6

2023-03-01

PREAI

Zakon, Danielle B.; Poncet, Coralie; Cardoso, Fatima; Anouk, Neven; Valero, Vicente; Aebi, Stefan; Benstead, Kim; Bogler, Oliver; Dal Lago, Lissandra; Fraser, Judith; Caballero, Carmela; Hedenfalk, Ingrid A.; Korde, Larissa A.; Linderholm, Barbro; Martens, John W. M.; Middleton, Lavinia P.; Murray, Melissa; Kelly, Catherine M.; Nilsson, Cecilia; Nowaczyk, Monika; Peeters, Stephanie; Beauvois, Melanie; Porter, Peggy; Schroder, Carolien P.; Rubio, Isabel T.; Ruddy, Kathryn; van Asperen, Christi; Van Den Weyngaert, Danielle; van Deurzen, Carolien H. M.; van Leeuwen-Stok, Elise; Vermeij, Joanna M.; Bartlett, John M. S.; Wolff, Antonio C.; Giordano, Sharon H.; Symmans, W. Fraser

Overall survival in the OlympiA phase Ill trial of adjuvant olaparib in patients with germime pathogenic variants in BRCA1/2 and high-risk, early breast cancer OlympiA iii期试验中辅助olaparib治疗BRCA1/2中germime致病变异和高危早期乳腺癌患者的总生存率

ANNALS OF ONCOLOGY

IF65.4

2022-12-01

198

OAAI

Geyer, C. E., Jr.; Garber, J. E.; Gelber, R. D.; Yothers, G.; Taboada, M.; Ross, L.; Rastogi, P.; Cui, K.; Arahmani, A.; Aktan, G.; Armstrong, A. C.; Arnedos, M.; Balmana, J.; Bergh, J.; Bliss, J.; Delaloge, S.; Domchek, S. M.; Eisen, A.; Elsafy, F.; Fein, L. E.; Fielding, A.; Ford, J. M.; Friedman, S.; Gelmon, K. A.; Gianni, L.; Gnant, M.; Hollingsworth, S. J.; Im, S-A; Jager, A.; Lakhani, S. R.; Janni, W.; Linderholm, B.; Liu, T-W; Loman, N.; Korde, L.; Loibl, S.; Lucas, P. C.; Marme, F.; de Duenas, E. Martinez; McConnell, R.; Phillips, K-A; Piccart, M.; Rossi, G.; Schmutzler, R.; Senkus, E.; Shao, Z.; Sharma, P.; Singer, C. F.; Spanic, T.; Stickeler, E.; Toi, M.; Traina, T. A.; Viale, G.; Zoppoli, G.; Park, Y. H.; Yerushalmi, R.; Yang, H.; Pang, D.; Jung, K. H.; Mailliez, A.; Fan, Z.; Tennevet, I; Zhang, J.; Nagy, T.; Sonke, G. S.; Sun, Q.; Parton, M.; Colleoni, M. A.; Schmidt, M.; Brufsky, A. M.; Razaq, W.; Kaufman, B.; Cameron, D.; Campbell, C.; Tutt, A. N. J.; Johannsson, O. Th

Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force

ESMO OPEN

IF8.3

2022-06-01

OAAI

Razis, E.; Escudero, M. J.; Palmieri, C.; Mueller, V.; Bartsch, R.; Rossi, G.; Gampenrieder, S. P.; Kolberg, H. C.; Zdenkowski, N.; Pavic, M.; Connolly, R. M.; Rosset, L.; Arcuri, J.; Tesch, H.; Vallejos, C.; Retamales, J.; Musolino, A.; DelMastro, L.; Christodoulou, C.; Aebi, S.; Paluch-Shimon, S.; Gupta, S.; Ohno, S.; Macpherson, I.; Ekholm, M.; Zaman, K.; Vidal, M.; Chakiba, C.; Fumagalli, D.; Thulin, A.; Witzel, I.; Kotecki, N.; Gil-Gil, M.; Linderholm, B.

Quality of life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05)

CANCER RESEARCH

IF16.6

2022-02-15

PREAI

Naughton, Michelle Joy; Zahrieh, David; Gnant, Michael; Zdenkowski, Nicholas; Lemieux, Julie; Mao, Jun J.; Bjelic-Radisic, Vesna; Shinn, Eileen; Balic, Marija; Thomssen, Christoph; Neisel, Jane; Ruiz-Echarri, Manuel; Loibl, Sibylle; Isaacs, Claudine; Cameron, David; Carrasco, Fernando Manuel Henao; Goetz, Matthew; Wette, Viktor; Werutsky, Gustavo; Rugo, Hope; Vetter, Marcus; Tseng, Ling-Ming; Miller, Kathy; Fitzal, Florian; Gil, Juan Miguel Gil; Park, Haeseong; Linderholm, Barbro; Bajetta, Emilio; Dayao, Zoneddy; Prat, Aleix; Ehrhardt, Karin; Metzger, Otto; Arahmani, Amal; Law, Ernest; Partridge, Ann; Carey, Lisa; Zoroufy, Alex; Dueck, Amylou; Hlauschek, Dominik; DeMichele, Angela; Mayer, Erica

Nordictrip, a translational randomized phase-3study exploring the effect of the addition of capecitabine to carboplatinum-based chemotherapy in early triple negative breast cancer, ClinicalTrials.gov Identifier: NCT04335669

CANCER RESEARCH

IF16.6

2022-02-15

PREAI

Loman, Niklas; Linderholm, Barbro; Ahlgren, Johan; Kimbung, Siker; Zander, Lina; Magnusson, Heidi Grill; Kjellman, Eva-Christin; Raaberg, Ann Julia; Jensen, Maj-Britt Raaby; Borg, Ake; Staaf, Johan; Stahlberg, Anders; Bendahl, Par-Ola; Laenkholm, Anne-Vibeke; Tanner, Minna; Bjarnadottir, Olof; Johannsson, Oskar; Ejlertsen, Bent; Lindman, Henrik

Discordance of PIK3CA and TP53 mutations between breast cancer brain metastases and matched primary tumors

SCIENTIFIC REPORTS

IF3.9

2021-12-07

OAAI

Thulin, Anna; Andersson, Carola; Ronnerman, Elisabeth Werner; De Lara, Shahin; Chamalidou, Chaido; Schoenfeld, Arnd; Kovacs, Aniko; Fagman, Henrik; Enlund, Fredrik; Linderholm, Barbro K.

Breaking Bad News in Cancer Care: Ethiopian Patients Want More Information Than What Family and the Public Want Them to Have

JCO GLOBAL ONCOLOGY

IF3

2021-12-01

OAAI

Woldemariam, Aynalem Abraha; Andersson, Rune; Munthe, Christian; Linderholm, Barbro; Lindstrom, Nataliya Berbyuk

研究方向